Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BRTX
#3994
BioRestorative Therapies, Inc. Common Stock (NV)
0.2
3
-4.17%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
-4.17%
Месячное изменение
-78.70%
6-месячное изменение
-85.44%
Годовое изменение
-85.16%
Предыдущее закрытие
0.2
4
Open
0.2
3
Bid
Ask
Low
0.2
3
High
0.2
3
Объем
5
Рынки
Рынок акций США
Здравоохранение
BRTX
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
6.92 M
7.5 M
7.5 M
7.98 M
8.88 M
—
Valuation ratios
Enterprise value
10.57 M
10.2 M
12.14 M
11.75 M
12.28 M
46.37 M
Price to earnings ratio
-1.26
-1.23
-1.2
-1.31
-0.99
-4.74
Price to sales ratio
8.52
10.92
15.24
13.08
16.74
55.98
Price to cash flow ratio
0.34
1.35
0.42
0.45
0.52
2.75
Price to book ratio
0.23
1.3
0.41
0.46
0.55
2.72
Enterprise value to EBITDA ratio
—
-0.95
—
—
—
—
Profitability ratios
Return on assets %
0.93
-0.13
-0.52
1.57
3.37
4.28
Return on equity %
1.36
-0.19
-0.87
2.75
8.61
10.3
Return on invested capital %
—
—
—
—
—
—
Gross margin %
54.92
24.62
17.68
78.09
1.77
122.16
Operating margin %
-583.2
-1 657.63
-3 847.07
-876.23
-5 333.64
-11.71 K
EBITDA margin %
—
-1 529.01
—
—
—
—
Net margin %
3 455.8
-1 008.18
-4 273
3 536.39
27.32 K
25.57 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.95
2.97
2.24
2.07
1.37
8.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.01
0.01
0.04
0.01
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.21
-0.3
-0.33
-0.31
-0.32
-1.26
EBIT per share
-0.26
-0.33
-0.56
-0.37
-0.4
-1.66
EBITDA per share
—
-0.32
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.61
1.38
1.09
0.84
0.49
3.81
Net current asset value per share
1.66
1.44
1.12
0.87
0.52
3.94
Tangible book value per share
1.15
1.02
0.66
0.49
0.18
2.34
Working capital per share
1.1
0.95
0.62
0.45
0.14
2.16
Book value per share
1.23
1.1
0.73
0.55
0.24
2.62
Новости
BioRestorative Therapies closes $5 million public offering
BioRestorative Therapies earnings beat by $0.05, revenue fell short of estimates
Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates
Cisco, Flutter, Manulife and more set to report earnings Wednesday
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
BioRestorative Therapies stock falls after $1.1M registered offering
BioRestorative Therapies raises $1.085 million in registered offering
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year?
BioRestorative Therapies earnings beat by $0.08, revenue fell short of estimates
BioRestorative Therapies, Inc. (BRTX) Q2 2025 Earnings Call Transcript